Dr. Alberto Lleó combines his clinical practice with translational research projects in the field of dementias, with a specific focus on the molecular bases of disease and biomarker development. His main contributions include the discovery of new genetic alterations in Alzheimer’s disease, the study of the gamma-secretase complex, and the identification of chemical biomarkers in Alzheimer’s disease and frontotemporal dementia.

Currently, he is Director of the Neurology Department at Hospital de Sant Pau in Barcelona, Coordinator of the Alzheimer’s Program at CIBERNED, and Associate Professor at the Universitat Autònoma de Barcelona (UAB). He leads a translational research group, directs multiple projects funded by public and private agencies, and actively collaborates with national and international research groups.

He has authored more than 20 book chapters and over 150 publications in international journals, and his work has been recognized with awards from the Spanish Society of Neurology.